AI takes on blood clotting: can ChatGPT guide surgeons on bleeding?

NCT ID NCT07043556

Terminated Knowledge-focused Sponsor: Ondokuz Mayıs University Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study evaluates whether artificial intelligence models can accurately interpret ROTEM blood clotting tests and recommend treatments for coagulopathy. Researchers will compare AI decisions to those of a panel of clinical experts using data from adults undergoing elective cardiac or liver transplant surgery. The goal is to see if AI can match expert-level judgment in identifying clotting problems and suggesting appropriate therapies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artificial intelligence algorithms (ChatGPT and Gemini) for ROTEM interpretation
What this could lead to: If AI can match expert doctors in reading ROTEM results, it could help standardize bleeding management and speed up treatment decisions during surgery.
What could go wrong: This is a small, early-stage observational study comparing AI to expert opinion, not a trial testing patient outcomes. AI may not perform well enough in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COAGULOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

blood coagulation disease vascular hemostatic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COAGULOPATHY

Contacts and locations

Locations

Ondokuz Mayis University

Samsun, Turkey (Türkiye)
İstanbul Aydın Üniversitesi Sağlık Uygulama ve Araştırma Merkezi Medical Park Florya Hastanesi

Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.